相关实验视频

Updated: Jun 7, 2025

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

[BCG治疗非肌肉侵入性膀癌:当前趋势的概述]

M Dymov A^1,2,3,4, A Lee Yu^1,2,3,4, P Korchagin M^1,2,3,4

¹Institute for Urology and Human Reproductive Health of FGAOU I.M. Sechenov First Moscow State Medical University, Moscow, Russia.

Urologiia (Moscow, Russia : 1999)

|November 20, 2024

概括

由于设施不足或药物短缺,三分之一的俄罗斯泌尿科医生避免在非肌肉侵入性膀癌 (NMIBC) 中使用静脉BCG治疗. 改善条件可以提高NMIBC患者的无复发生存率.

科学领域:

泌尿器科泌尿器科泌尿器科泌尿器科
在瘤学瘤学.
免疫治疗是一种免疫疗法.

背景情况:

非肌肉侵入性膀癌 (NMIBC) 的复发率高 (70%) 和进展风险高 (20%).
肠道 Calmette-Guérin (BCG) 疗法对于增加中期和高风险NMIBC中无复发的生存率至关重要.
这项研究研究了目前在俄罗斯的静脉内BCG治疗的应用.

研究的目的:

评估在俄罗斯泌尿病学会的泌尿科医生中使用静脉BCG疗法.
确定阻碍BCG疗法在NMIBC治疗中的广泛采用障碍.

主要方法:

在145名俄罗斯泌尿科医生中进行了一项调查.
该调查收集了关于BCG疗法处方实践,非处方原因和经历困难的数据.

主要成果:

在接受调查的泌尿科医生中,有32%的人没有为NMIBC开布BCG治疗.
主要障碍包括缺乏足够的设施 (74%) 和药物不可用 (20%).
免疫疫苗 (69%) 是最常被处方的BCG药物,只有8%的医生报告没有治疗困难.

结论:

相当一部分泌尿科医生面临的挑战是在注射静脉BCG治疗.
解决设施限制和药物供应问题对于优化BCG免疫疗法对NMIBC患者至关重要.
改善静脉内免疫疗法的条件可以提高NMIBC的无复发生存率.

关键词:

在BCG治疗中,BCG疗法是最有效的.膀癌:膀癌是一种癌症.在心脏病学上,心脏病学是心脏病学.调查调查调查调查调查调查调查调查

更多相关视频

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Published on: December 28, 2021

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...